precisionbiosciences.com (DTIL): Net earnings per share growth forecast for next year
Despite its dependence on external capital and hypothetical risks regarding the toxicity of in vivo methods, Precision BioSciences (DTIL) continues to drive innovation. The forward-looking earnings per share growth forecast reflects the market's reaction to these factors, with 15.20 representing the current level of the metric. The robotization of screening via ARCUS AI systems eliminates routine tasks, creating an ecosystem for the treatment of cancer and genetic pathologies.
DTIL (precisionbiosciences.com): analytical breakdowns and indicator data
- price and consensus price forecast:
- stock exchange capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Capital Precision BioSciences|DTIL - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Precision BioSciences, Inc.|DTIL - Company Cumulative Debt|Debt to Book Capitalization Ratio Precision BioSciences|DTIL - Long-Term Debt Volume|Company Short-Term Debts Precision BioSciences|Quick Ratio precisionbiosciences.com
- earnings and market ratios statistics:
DTIL - Net Financial Result|Projected Future Earnings Precision BioSciences|DTIL - Market Cap to Earnings|Future Price to Earnings Precision BioSciences|DTIL - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Precision BioSciences|DTIL - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Precision BioSciences|DTIL - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months precisionbiosciences.com|DTIL - Expected net earnings per share growth this year|Earnings growth forecast for next year Precision BioSciences
Fundamental company analysis:DTIL, Precision BioSciences
This indicator reflects the consensus forecast for earnings per share dynamics, measuring the expected growth rate of net yield in the next fiscal period. By analyzing the projected EPS growth for the coming year, an investor determines the degree of market optimism and the risks of a price correction should targets not be met. For Precision BioSciences (DTIL), this metric discounts the long-term potential of licensing the proprietary ARCUS platform, which creates a sustainable revenue stream.
Competitor analysis
Net earnings per share growth forecast for next year Tempus AI, Inc|Expected net earnings per share growth next year Qiagen Corp QGEN|Net earnings per share growth forecast for next year Ionis Pharmaceuticals (IONS)|repligen.com - Projected earnings per share growth rate for next year|Avidity Biosciences, Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year CRSP|Sema4 - Earnings growth forecast for next year|RARE: Net earnings per share growth forecast for next year|BEAM: Earnings growth forecast for next year|SRPT - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Twist Bioscience, Inc.|Expected net earnings per share growth next year 10x Genomics Inc TXG|Net earnings per share growth forecast for next year Intellia (NTLA)|Consensus forecast of earnings per share growth for next year Stoke Corp|Earnings growth forecast for next year BLFS (BioLife Solutions, Inc.)|WVE - Expected earnings per share growth for next year|Maze Therapeutics - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Sionna Therapeutics, Inc. SION|PRME: Earnings growth forecast for next year|Expected net earnings per share growth next year Taysha Corp (TSHA)|Net earnings per share growth forecast for next year uniQure N.V.|Projected earnings per share growth rate for next year MGTX (meiragtx.com)|Earnings growth forecast for next year RGNX|Expected earnings per share growth for next year Solid Biosciences Inc SLDB|Earnings growth forecast for next year OCGN (Ocugen Corp)|PacBio Corp (PACB) - Expected net earnings per share growth next year|BNTC - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year designtx.com DSGN|RCKT: Earnings growth forecast for next year|Projected earnings per share growth rate for next year FDMT|Expected earnings per share growth for next year LXEO|KRRO (Korro Bio, Inc) - Projected earnings per share increase next year|Earnings growth forecast for next year EDIT|Consensus forecast of earnings per share growth for next year silence-therapeutics.com|Net earnings per share growth forecast for next year ProQR Therapeutics PRQR|Codexis Inc - Net earnings per share growth forecast for next year|Sangamo - Earnings growth forecast for next year|NAUT (Nautilus Biotechnology) - Projected earnings per share growth rate for next year|Metagenomi, Inc. (MGX) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year GBIO|BOLD (Boundless Bio) - Earnings growth forecast for next year|Earnings growth forecast for next year Exicure Corp|Net earnings per share growth forecast for next year Imunon, Inc. (IMNN)|PHIO: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Mustang Bio MBIO|Expected earnings per share trend next year RNAZ|Bionano - Earnings growth forecast for next year|Expected net earnings per share growth next year Applied DNA Sciences Inc|BLUE: Earnings growth forecast for next year|Expected earnings per share growth for next year ImmunoPrecise Antibodies Ltd.|OMGA (Omega Therapeutics) - Earnings growth forecast for next year|singulargenomics.com (OMIC) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Regulus Therapeutics Inc. (RGLS)|Consensus forecast of earnings per share growth for next year Syros Pharmaceuticals Inc.|Earnings growth forecast for next year TBIO (Codex DNA)|Consensus forecast of earnings per share growth for next year TRACON Pharmaceuticals, Inc (TCON)|UBX - Net earnings per share growth forecast for next year
